Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aroclav-LB
- Development stage
- Unknown
- Lead developer
- Aareen Healthcare
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Aroclav-LB is an oral combination antibiotic and probiotic tablet developed and marketed by Aareen Healthcare in India. It contains amoxicillin (500mg), a beta-lactam antibiotic that targets bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs); clavulanic acid (125mg), a beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation by resistant bacteria; and Lactobacillus (60 million spores), a probiotic included to maintain healthy gut flora and prevent antibiotic-associated diarrhea. This combination is used to treat a wide range of bacterial infections while minimizing gastrointestinal side effects commonly associated with broad-spectrum antibiotic therapy.
- Brand names
- Aroclav-LB
- Other names
- Amoxicillin + Potassium Clavulanate + Lactobacillus
02
Targets
β-lactamasePBP (Penicillin-binding protein family)
Beyond the preview
Go deeper on Aroclav-LB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aroclav-LB.